Quality Metrics and Operational Efficiency
Apollo Hospitals Enterprise continues to demonstrate robust operational performance, underscored by a return on capital employed (ROCE) of 16.84% for the latest period. This figure indicates a strong capacity to generate returns from its capital base, reflecting efficient management practices. The company’s ability to service debt remains sound, with a Debt to EBITDA ratio of 1.48 times, suggesting manageable leverage levels relative to earnings.
Net sales have exhibited a compound annual growth rate of 16.66%, while operating profit margins stand at 37.14%, signalling sustained profitability. The firm has reported positive results for eight consecutive quarters, with the half-year ROCE reaching 16.11% and operating profit to interest coverage at 8.59 times, highlighting financial resilience. Quarterly net sales peaked at ₹6,303.50 crores, reinforcing the company’s strong market position.
Our latest monthly pick, this Large Cap from Aluminium & Aluminium Products, is outperforming the market! See the analysis that helped our Investment Committee select this winner.
- - Market-beating performance
- - Committee-backed winner
- - Aluminium & Aluminium Products standout
Valuation Considerations
The valuation perspective on Apollo Hospitals Enterprise reflects an attractive profile relative to its sector peers. The company’s ROCE of 17.9% aligns with an enterprise value to capital employed ratio of 7.9, indicating that the stock is trading at a discount compared to historical averages within the hospital industry. This valuation metric suggests that the market may be pricing in certain risks or uncertainties despite the company’s solid fundamentals.
Over the past year, the stock has generated a return of 6.10%, while profits have increased by 41.3%, resulting in a price/earnings to growth (PEG) ratio of 1.5. This ratio implies a moderate balance between earnings growth and market price, which investors may interpret as a signal to reassess expectations. The company’s market capitalisation stands at ₹1,05,696 crores, making it the second largest in its sector and accounting for 18.47% of the hospital industry’s total market value.
Financial Trend Analysis
Examining the financial trajectory, Apollo Hospitals Enterprise has delivered consistent returns over multiple time horizons. The stock’s cumulative return over ten years is 453.14%, significantly outpacing the Sensex’s 229.38% over the same period. Similarly, three-year returns of 52.75% surpass the benchmark’s 36.34%, underscoring the company’s long-term growth potential.
However, more recent performance shows a mixed picture. Year-to-date returns stand at 0.75%, trailing the Sensex’s 8.65%, while the one-month and one-week returns are negative at -6.18% and -1.83% respectively, compared to positive benchmarks. This divergence may reflect short-term market volatility or sector-specific challenges impacting investor sentiment.
Despite these fluctuations, the company’s financial results for the second quarter of fiscal year 2025-26 indicate continued strength, with net sales and operating profit maintaining upward momentum. The firm’s ability to sustain positive quarterly results over two years demonstrates operational stability amid evolving market conditions.
Technical Indicators and Market Sentiment
The technical landscape for Apollo Hospitals Enterprise has shifted towards a more cautious stance. Weekly and monthly Moving Average Convergence Divergence (MACD) indicators show mildly bearish signals, while the Relative Strength Index (RSI) remains neutral with no clear directional signal. Bollinger Bands present a mixed view, with weekly data indicating bearish tendencies and monthly data suggesting mild bullishness.
Other technical measures such as the Know Sure Thing (KST) oscillator and Dow Theory analysis reflect subdued momentum, with weekly and monthly readings leaning mildly bearish or showing no definitive trend. On-Balance Volume (OBV) data indicates no clear trend on a weekly basis but mild bullishness monthly, suggesting some accumulation despite price softness.
Daily moving averages maintain a mildly bullish posture, but the overall technical trend has transitioned from mildly bullish to sideways, signalling a period of consolidation. This technical shift may be influencing the recent revision in market assessment, as investors weigh short-term price action against longer-term fundamentals.
Apollo Hospitals Enterprise . or something better? Our SwitchER feature analyzes this large-cap Hospital stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Sector Position and Market Capitalisation
Apollo Hospitals Enterprise holds a significant position within the hospital sector, with annual sales of ₹23,264.70 crores representing nearly 30% of the industry’s total revenue. Its market capitalisation places it as the second largest company in the sector, trailing only Max Healthcare. This dominant presence underscores the company’s influence on sector dynamics and investor interest.
Despite this stature, promoter confidence appears to be waning, as indicated by a reduction in promoter shareholding by 1.32% over the previous quarter, bringing their stake to 28.02%. Such a decrease may be interpreted as a signal of cautious outlook from insiders, potentially reflecting concerns about future growth prospects or market conditions.
Summary and Outlook
The recent revision in Apollo Hospitals Enterprise’s evaluation reflects a complex interplay of factors. Quality metrics remain strong, with efficient capital utilisation and consistent profitability. Valuation measures suggest the stock is trading at a relative discount, though recent returns have been mixed compared to broader market indices. Financial trends highlight long-term growth and resilience, while technical indicators point to a more neutral to cautious market sentiment.
Investors analysing Apollo Hospitals Enterprise should consider these multifaceted elements, balancing the company’s solid fundamentals against evolving market dynamics and technical signals. The reduction in promoter stake adds an additional dimension to the assessment, warranting close observation of future developments.
Overall, the shift in market assessment underscores the importance of a holistic approach to stock evaluation, integrating quality, valuation, financial trends, and technical analysis to form a comprehensive view of investment potential.
Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
